Harold Robert Meyer
The ADD Resource Center · Reviewed July 23, 2026 · Published July 25.2026
A yearly conversation about where you were, where you are, and what is coming is already a published standard of care. Almost nobody gets one.
Most ADHD appointments are built around the next ninety days. Is the dose holding, any side effects, here is the script, see you in three months. Nothing is wrong with that visit. It is simply short, and it never asks the longer question: over the past year, did any of this make your life better?
Key Takeaway
Yes – Once a year, request an appointment to discuss this, rather than just the refill. Talk about where you were, where you are now, and what the next twelve months will require.
Why This Matters
ADHD is managed in ninety-day increments and lived in years. The decisions get made at increment scale: a dose nudged, a side effect tolerated, a support quietly dropped, a goal abandoned so gradually that nobody logs the moment. No one stands back to see what those small decisions added up to. An annual review is where the standing back happens, and it is the only appointment at which “is this still the right treatment plan?” can be answered honestly.
Key Findings
- NICE guidance (National Institute for Health and Care Excellence) directs a clinician with training and expertise in ADHD to review medication at least once a year and to discuss with the person whether it should continue – covering benefit across the whole day, adverse effects, effects on other physical or mental health conditions, and whether non-medication support is needed.
- The American Academy of Pediatrics classifies ADHD as a chronic condition to be managed under the chronic care model, not handled episodically.
- In the MTA follow-up study, Sibley and colleagues found 63.8% of participants had fluctuating periods of remission and recurrence; only 9.1% showed sustained recovery and only 10.8% showed stable persistence.
- A plan built for the person you were three years ago is unlikely to fit the person you are now.
A year is the right interval, and that is not just a preference
The NICE guideline sets an explicit floor: ADHD medication gets reviewed at least annually, with the person present in the decision about whether to continue. The AAP guideline makes the parallel point structurally – ADHD belongs with the chronic conditions, managed continuously rather than in episodes.
Neither document guarantees you a real conversation. In practice the annual review often collapses into the same fifteen minutes as the refill. The interval is defensible; the content is what you have to protect.
Your course is probably fluctuating
The strongest argument for revisiting the plan is that the condition itself moves. Tracking 558 children into their mid-twenties, Sibley and colleagues found that the tidy story – roughly half outgrow it – does not survive longitudinal measurement. Only 9.1% reached sustained recovery. Only 10.8% were stably persistent. Nearly two-thirds moved back and forth. About 30% had a stretch of full remission, and 60% of those relapsed.
If the presentation is that mobile, an unrevised treatment plan is not stability. It is drift.
Where you were
You cannot review a year you cannot reconstruct, and ADHD tilts recall in a specific direction: the last two weeks impersonate the last twelve months. A bad fortnight becomes “nothing is working.” A good one becomes “I’m fine.”
So bring the year in on paper. One page: what changed (job, school, medication, sleep, relationships, other prescriptions), what improved, what deteriorated, what you stopped doing and why.
“Memory is not evidence. Walk in with a page and you are reviewing a year. Walk in without one and you are reviewing your mood that morning.” – Harold Robert Meyer
Where you are
Four things are worth a deliberate look every year.
Functioning, not symptom counts. Ratings scales are useful, but the review question is whether the plan protects your work, your schooling, your money, and your relationships. Late fees, performance reviews, unopened mail, and the state of your closest relationships are data.
Coverage across the whole day. Many plans are optimized for the morning. Whether the evening holds is a separate question, and it is where family life actually happens.
Physical and comorbid status. Blood pressure, pulse, weight, sleep. New comorbid conditions – depression, anxiety, substance use – frequently arrive years after the ADHD diagnosis and change what the right treatment is.
Everything that is not medication. Coaching, therapy, accommodations, structure. These are the elements that get dropped silently, and their absence is rarely noticed at a refill visit.
What the next year will ask of you
Then turn the conversation forward, because the load changes. Middle school to high school. College. A promotion into managing people. A new baby, a divorce, a parent who now needs care. Perimenopause. Retirement, which removes the external structure that was doing quiet work for decades.
Name what is coming and ask directly whether the current plan covers it. Adjusting in advance of a known transition is ordinary chronic care. Waiting for the transition to break something is not.
Getting the appointment
Request it as its own visit and say why: “I’d like to schedule a longer appointment to review the past year and plan the next one, separate from a medication check.” Anchor it to something you will not forget – your birthday month, or the start of the school year. Bring the page. Ask for the resulting plan in writing before you leave.
If a partner, parent, or adult child sees things you do not, bring them or their notes, with everyone’s agreement.
If the answer is no
Some clinicians have no room in their schedule for this. You can still do most of it: run the review yourself, hand over the page, and ask for a written response. But if the answer every year is that there is time for the prescription and nothing else, that is real information about whether the fit still works – as is a second opinion, which is due diligence rather than disloyalty.
Bibliography
National Institute for Health and Care Excellence. (2019). Attention deficit hyperactivity disorder: Diagnosis and management (NICE guideline NG87; published 2018, updated 2019). https://www.nice.org.uk/guidance/ng87/chapter/recommendations
Sibley, M. H., Arnold, L. E., Swanson, J. M., Hechtman, L. T., Kennedy, T. M., Owens, E., Molina, B. S. G., Jensen, P. S., Hinshaw, S. P., Roy, A., Chronis-Tuscano, A., Newcorn, J. H., & Rohde, L. A.; MTA Cooperative Group. (2022). Variable patterns of remission from ADHD in the Multimodal Treatment Study of ADHD. American Journal of Psychiatry, 179(2), 142–151. https://doi.org/10.1176/appi.ajp.2021.21010032
Wolraich, M. L., Hagan, J. F., Allan, C., Chan, E., Davison, D., Earls, M., Evans, S. W., Flinn, S. K., Froehlich, T., Frost, J., Holbrook, J. R., Lehmann, C. U., Lessin, H. R., Okechukwu, K., Pierce, K. L., Winner, J. D., & Zurhellen, W. (2019). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 144(4), e20192528. https://doi.org/10.1542/peds.2019-2528
Resources
From The ADD Resource Center
- Talk to Your Doctor with ADHD: Get the Care You Need
- Essential ADHD Doctor Appointment Checklist: Maximize Your Visit
- How do you know your ADHD medication is working?
- ADHD and Polypharmacy: Essential Questions to Ask Your Doctors
- Common Comorbidities Associated with ADHD, Along with Typical Ages of Onset
Elsewhere
- NICE Quality Standard QS39, Statement 7: Annual review of drug treatment
- CDC: Clinical Care of ADHD in Children
- CHADD: Medication Management (adults)
The next step
Open your calendar and put a two-hour block in one month from today labeled “ADHD year in review.” Spend the first hour writing your page. Spend the second calling to book the appointment.
About the Author
Harold Robert Meyer founded The ADD Resource Center in 1993 and has spent more than thirty years translating the lived experience of ADHD into practical guidance for individuals and for the professionals who serve them. He co-founded CHADD of New York in 1989, served on CHADD National’s board and executive committee, including as its VP Finance, and was elected to lead the Institute for the Advancement of ADHD Coaching. Reach him at [email protected].
📚 Come back often — we add new evidence-based ADHD resources daily.
The ADD Resource Center
[email protected] · +1 (646) 205-8080 · 127 West 83rd St., Unit 133, Planetarium Station, New York, NY 10024-0840 USA
X · LinkedIn · Facebook · Substack · Newsletter
Please consider the environment before printing.
Our content is for educational and informational purposes only and is not a substitute for professional advice. We strive for accuracy, though errors can occur. Some material may be AI-generated; please verify independently.
Rejection Sensitive Dysphoria (RSD) is recognized by many providers but is not in the DSM.
In the USA and Canada, call or text 988 anytime for free mental health and suicide prevention support. The ADD Resource Center is independent from this service and is not liable for any actions taken by you or the 988 service.
Under GDPR and CCPA, you may request access to, correction of, or deletion of your personal data at [email protected].
© 2026 The ADD Resource Center. All rights reserved. Reprint permission: [email protected]